The discussion focuses on GLP-1 drugs, which are gaining popularity for weight loss. While licensed for this use in India, concerns are rising about their misuse as a "cosmetic shortcut." The programme examines the serious potential side effects, including claims of blindness, stomach paralysis, and an increased risk of thyroid cancer, which are part of a lawsuit filed in the United States against the drug Ozempic.
#indiatoday #ozempic #weightloss #itwebvideos #glp1
Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you’ll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India’s leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.
Stay tuned for latest updates and in-depth analysis of news from India and around the world!
WhatsApp Channel: https://whatsapp.com/channel/0029Va2AnW3JENxxg7OuJv00
Download App: https://indiatoday.link/wHaj
Follow us: Official website: https://www.indiatoday.in/
Twitter: https://twitter.com/IndiaToday
Facebook: https://www.facebook.com/IndiaToday
